Navigation Links
Accumed Research Associates Featured On Katz's Corner 77 WABC Radio Show To Discuss Enlarged Prostate Treatment and Clinical Trials In Urology
Date:1/13/2014

Garden City, New York (PRWEB) January 13, 2014

Mitchell Efros MD FACS, President and Medical Director of Accumed Research Associates appeared on Katz's Corner News Talk Radio 77 WABC to discuss clinical research as an option for medical care. Visit Katz's Corner Accumed Research January 14, 2014 and listen to the January 12th, 2014 podcast to hear the entire broadcast.

Accumed Research Associates offers enlarged prostate (BPH) treatment for men that experience symptoms. The various clinical trials may provide novel therapeutic alternatives for men suffering with urinary problems referred to as lower urinary tract symptoms (LUTS). The clinical trials offered are for men who are naive to treatment and those that have tried other therapies other than surgery before. Accumed Research Associates provides enlarged prostate (BPH) treatment on Long Island, New York.

Accumed Research Associates also conducts clinical trials for men with low testosterone, prostate cancer, men and women with overactive bladder and urinary incontinence or frequent urination, as well as healthy volunteer studies. Dr. Efros reviewed the steps necessary to participate in a clinical trial and how clinical trials advance medical therapy and bring potential added value to the patient.

Dr. Mitchell Efros MD FACS, Medical Director and President of Accumed Research Associates stated, "Clinical trials provide alternatives to the standard forms of therapy that are currently available."

About Accumed Research Associates:
Accumed Research Associates has been providing expert urologic care for over 14 years by a board certified urologist and seasoned compassionate healthcare providers. Located in Garden City, New York Accumed Research Associates provides alternatives and cutting edge medication and technology. Contact Accumed Research Associates at 1 (888) 746-2190 or visit us and register on our website at http://www.accumedresearch.com.

Read the full story at http://www.prweb.com/releases/AccumedResearchNewsTalk/RadioShowClinicalTrials/prweb11482440.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Penn research helps lay out theory for metamaterials that act as an analog computer
2. Louisiana’s First Clinical Data Research Network to Be Developed Through PCORI Funding
3. Capsugel’s Bend Research to Present New Processes for Flu Vaccine and Other Science Advancements at Upcoming Industry Meetings
4. New Insights on the Decline of Research and Development in Pharma & Biotech
5. New Jersey Health Foundation President Addresses Panel at AAHC Research Efficiency Conference
6. Cardio3 BioSciences, a European biopharmaceutical company, now covered by Edison Investment Research
7. Nanomedicine Market is Expected to Reach USD 177.60 Billion Globally in 2019: Transparency Market Research
8. Elsevier Launches the New Generation SciVal, Providing Dynamic Real-Time Analytics and Insights into the Global Research Landscape
9. Paraformaldehyde Industry 2014 Global & China Development Analysis in a New Research Study Available at DeepResearchReports.com
10. Researchers find that computer components can be damaged by key manufacturing processes
11. PCCI Collaborates With UTSW On Top National Research Grants Totaling Over $30 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016  Regular discussions on a range of subjects including ... two entities said Poloz. Speaking at a lecture ... , he pointed to the country,s inflation target, which is ... "In certain areas there ... common economic goals, why not sit down and address strategy ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Researchers at ... most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the ... read it now. , Diagnostic biomarkers are signposts in the blood, lung fluid ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
(Date:6/23/2016)... Houston Methodist Willowbrook Hospital has signed ... to serve as their official health care provider. ... will provide sponsorship support, athletic training services, and ... volunteers, athletes and families. "We are ... and to bring Houston Methodist quality services and ...
Breaking Biology Technology:
(Date:6/2/2016)... --  The Weather Company , an IBM Business (NYSE: ... in which consumers will be able to interact with IBM ... voice or text and receive relevant information about the product ... have long sought an advertising solution that can create a ... and valuable; and can scale across millions of interactions and ...
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC , ... announced the opening of an IoT Center of Excellence ... and expand the development of embedded iris biometric applications. ... level of convenience and security with unmatched biometric accuracy, ... identity aside from DNA. EyeLock,s platform uses video technology ...
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
Breaking Biology News(10 mins):